Congress Asset Management »

Supernus Pharmaceuticals shares owned by Congress Asset Management

Quarter-by-quarter ownership of Supernus Pharmaceuticals (SUPN) shares owned by Congress Asset Management from 13F filings

Historical chart of Congress Asset Management investment in Supernus Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Supernus Pharmaceuticals held by Congress Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Supernus Pharmaceuticals by Congress Asset Management

Quarter filed Position value Share count Share price at filing
2024-03-31 $35M 1.0M 34.11
2023-12-31 $27M 921k 28.94
2023-09-30 $25M 917k 27.57
2023-06-30 $23M 770k 30.06
2023-03-31 $20M 561k 36.23
2022-12-31 $18M 507k 35.67
2022-09-30 $17M 508k 33.85
2022-06-30 $14M 482k 28.92
2022-03-31 $15M 464k 32.32
2021-12-31 $12M 396k 29.16
2021-09-30 $8.4M 314k 26.67
2021-06-30 $9.1M 295k 30.79